3PL | California Designated Representative 3PL Training Course

for third-party logistics providers

According to the California State Board of Pharmacy, “To be licensed as a Designated Representative – 3PL in California, you must satisfy the requirements under Business and Professions Code section 4053.1. Each place of business of a third-party logistics provider shall be supervised and managed by a responsible manager. The responsible manager shall be responsible for the compliance of the place of business with state and federal laws governing third-party logistics providers and with the third-party logistics provider’s customer specifications, except where the customer’s specifications conflict with state or federal laws. The responsible manager shall maintain an active license as a designated representative-3PL with the board at all times during which he or she is designated as the responsible manager.”

About Our California Designated Representative 3PL Training Course

Purchase now to enter the online classroom – Calif Des Rep 3PL Training Course

  • $525 per student
  • This training program is approved by the California State Board of Pharmacy (“Board”)
  • Covers topics required by the Board (specified by the license application training affidavit)
  • Designed for California Designated Representative 3PL license applicants and their supervisors
  • Web-based. Self-study. Come-and-go as needed.
  • It’s fast (typically lasting < 8 hours)
  • Includes subject/topic exams
  • Successful course completion earns you a training affidavit (to include in your California Designated Representative-3PL license application).
  • Trust our experience. Since 2002, nearly 7,000 students have taken one of our state license-related training courses.

Questions? Give us a call: (415) 948-5220

California Designated Representative 3PL online training course. Image of a glowing blue laptop in darkness. Board approved California Designated Representative-3PL training course.
3PL | California Designated Representative 3PL Training Course

Go to DREprof.com: The Designated Representative and Exemptee Training Website

Countering Counterfeiters and Diverters – PharmTech

According to the article:

Counterfeiting countermeasures

The pharmaceutical industry has been on the leading edge of anticounterfeiting and brand protection efforts for many years. “Anticounterfeit solutions are usually tailor-made according to the needs of the brand owner,” says Paavo Sillanpää, senior business manager, Pharma at UPM Raflatac.

A diverse strategy considering threat scenario and product is needed. “Most pharma companies have a multi-layered approach,” notes Farrell. The most common physical solutions are tamper-evident labels and packaging materials, designs that prevent the placement of a counterfeit product into the original packaging, serialization, and overt and covert authentication methods such as holograms, invisible markers, and taggants. “Ideally, multi-level security concepts should be used that are individually tailored to a specific use case, combining analog and digital features, which can be verified by different stakeholders within the supply chain,” says Dul.”

Read the full source article: Countering Counterfeiters and Diverters – PharmTech.com


Go to DREprof.com: The Designated Representative and Exemptee Training Website

COVID-19: 90-Day Refills May Strain Supply Chain – Specialty Pharmacy Continuum

According to the article:

“Across the country, pharmacies have been seeing a significant uptick in patients seeking to extend 30-day prescriptions to 90 days to ensure access to their medications amid the growing COVID-19 crisis. While stakeholders say they have been able to meet these requests, several indicate that it’s only a matter of time before the supply chain buckles under these new pressures.”

Read the source article:  COVID-19: 90-Day Refills May Strain Supply Chain – Specialty Pharmacy Continuum


Go to DREprof.com: The Designated Representative and Exemptee Training Website

Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights

According to the article:

“Blockchain startup Mediledger has published the results of its FDA blockchain pilot for the pharmaceutical supply chain. Numerous separate groups applied to the FDA and ran pilots for the Drug Supply Chain Security Act (DSCSA) 2023 milestone for package-level tracing, with this being one of the largest groups. Mediledger’s participants included all three major U.S. wholesalers, seven out of ten of the world’s largest pharmaceutical companies, massive dispensers Walgreens and Walmart, as well as logistics firms such as FedEx.”

Read the source article:  Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights


Go to DREprof.com: The Designated Representative and Exemptee Training Website